BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24801211)

  • 1. Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.
    Zhang T; Zhang Y; Zhang C; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
    PLoS One; 2014; 9(5):e96651. PubMed ID: 24801211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and its components as predictors of nonalcoholic fatty liver disease in a northern urban Han Chinese population: a prospective cohort study.
    Zhang T; Zhang C; Zhang Y; Tang F; Li H; Zhang Q; Lin H; Wu S; Liu Y; Xue F
    Atherosclerosis; 2015 May; 240(1):144-8. PubMed ID: 25785362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.
    Ryoo JH; Choi JM; Moon SY; Suh YJ; Shin JY; Shin HC; Park SK
    Atherosclerosis; 2013 Apr; 227(2):398-403. PubMed ID: 23390894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.
    Cai X; Gao J; Hu J; Wen W; Zhu Q; Wang M; Liu S; Hong J; Wu T; Yang S; Tuerxun G; Li N
    Dis Markers; 2022; 2022():4930355. PubMed ID: 35251371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study.
    Wang S; Zhang C; Zhang G; Yuan Z; Liu Y; Ding L; Sun X; Jia H; Xue F
    BMJ Open; 2016 Jun; 6(6):e010342. PubMed ID: 27251683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study.
    Pastori D; Sciacqua A; Marcucci R; Del Ben M; Baratta F; Violi F; Pignatelli P;
    Intern Emerg Med; 2021 Nov; 16(8):2063-2068. PubMed ID: 33713286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome.
    Bae JC; Kim SK; Han JM; Kwon S; Lee DY; Kim J; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    Diabetes Res Clin Pract; 2017 Jul; 129():136-143. PubMed ID: 28527304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
    Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported snoring is associated with nonalcoholic fatty liver disease.
    Wang H; Gao Q; He S; Bao Y; Sun H; Meng L; Liang J; Sun C; Chen S; Cao L; Huang W; Zhang Y; Huang J; Wu S; Wang T
    Sci Rep; 2020 Jun; 10(1):9267. PubMed ID: 32518245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Liver Enzymes among the Patients with Metabolic Syndrome with or without Non Alcoholic Fatty Liver Disease attending a Tertiary Care Hospital.
    Mondal E; Karim MR; Begum A; Hassan K; Noor SM; Khan MM; Khan KH; Ashrafuzzaman SM
    Mymensingh Med J; 2023 Apr; 32(2):338-347. PubMed ID: 37002743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between non-alcoholic fatty liver disease and metabolic syndrome in patients with latent autoimmune diabetes in adults].
    Yu TP; Zhao CC; Chen MY; Lu JX; Li LX; Jia WP
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2398-2402. PubMed ID: 30138983
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese.
    Hou XH; Zhu YX; Lu HJ; Chen HF; Li Q; Jiang S; Xiang KS; Jia WP
    J Gastroenterol Hepatol; 2011 Apr; 26(4):722-30. PubMed ID: 21418302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
    Zheng K; Yin Y; Guo H; Ma L; Liu R; Zhao T; Wei Y; Zhao Z; Cheng W
    Front Endocrinol (Lausanne); 2024; 15():1340644. PubMed ID: 38405152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.
    Cho YK; Kang YM; Yoo JH; Lee J; Lee SE; Yang DH; Kang JW; Park JY; Jung CH; Kim HK; Lee WJ
    Sci Rep; 2018 Aug; 8(1):12004. PubMed ID: 30104707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal.
    Pardhe BD; Shakya S; Bhetwal A; Mathias J; Khanal PR; Pandit R; Shakya J; Joshi HO; Marahatta SB
    BMC Gastroenterol; 2018 Jul; 18(1):109. PubMed ID: 29980170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: A prospective, community-cohort study.
    Niriella MA; Kasturiratne A; Beddage TU; Withanage SA; Goonatilleke DC; Abeysinghe CP; De Mel RT; Balapitiya TL; De Silva ST; Dassanayake AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; de Silva HJ
    Liver Int; 2020 Jan; 40(1):101-106. PubMed ID: 31472085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary patterns and risk of non-alcoholic fatty liver disease in adults: A prospective cohort study.
    Zhang S; Gu Y; Bian S; Górska MJ; Zhang Q; Liu L; Meng G; Yao Z; Wu H; Wang Y; Zhang T; Wang X; Sun S; Wang X; Zhou M; Jia Q; Song K; Qi L; Niu K
    Clin Nutr; 2021 Oct; 40(10):5373-5382. PubMed ID: 34560608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.